Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Masimo Corp
(NQ:
MASI
)
133.89
+0.79 (+0.59%)
Streaming Delayed Price
Updated: 1:40 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Masimo Corp
< Previous
1
2
3
4
5
6
7
Next >
Apple's $17B Smartwatch Business At Risk, Cutting-Edge AI Tech 'HUGS' And More: This Week In Appleverse
December 24, 2023
From threats to its smartwatch operations to a significant increase in its card savings interest rate, let's delve into the Apple-centric news that unfolded this past week.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Dow Jones Giants Apple, Microsoft Lead Five Stocks Near Buy Points
December 23, 2023
Investors should keep tabs on these five stocks trading tightly.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
'They Haven't Called:' Masimo CEO Awaits Apple's Move In Watch Patent Infringement Dispute
December 20, 2023
Masimo CEO Joe Kiani has expressed willingness to settle the ongoing patent dispute with Apple related to the Apple Watch Ultra 2 and Apple Watch Series 9, saying that the tech giant has not initiated...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Biden Administration 'Tracking' Apple Watch Case — Could White House Veto The Ban?
December 19, 2023
The Biden administration is closely monitoring a potential ban on Apple Watch sales in the U.S. due to a patent dispute with Masimo Corp, with the U.S. Trade Representative considering whether to lift...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Recap: Masimo Q3 Earnings
November 07, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Masimo
August 09, 2023
Via
Benzinga
Why Shares of Masimo Are Dropping Tuesday
July 18, 2023
The company's preliminary second-quarter numbers have investors worried.
Via
The Motley Fool
Apple Scrambles To Save $17B Smartwatch Business From Impending Ban: Report
December 18, 2023
Apple is reportedly working to salvage its $17 billion smartwatch business from an impending U.S. ban, set to take effect on Dec. 25, by tweaking algorithms related to blood oxygen level measurement,...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
November 21, 2023
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...
Via
Benzinga
Topics
ETFs
Wells Fargo Maintains Equal-Weight Rating for Masimo: Here's What You Need To Know
November 08, 2023
Via
Benzinga
Robinhood, eBay, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
November 08, 2023
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Big Tech Earnings, Results From a Couple of Financial Companies, and a Look at Spotify
November 05, 2023
We also chat with author Michael Lewis about Sam Bankman-Fried.
Via
The Motley Fool
Masimo Might See Potential Royalty Windfall From ITC's Exclusion Order On Apple Watch: Analyst
October 27, 2023
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI)
Via
Benzinga
Masimo Surges After Winning A Potential $100 Million Battle Against Apple
October 27, 2023
Federal officials say Apple violated patent laws in its Apple Watch.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
Nasdaq, S&P 500 Eye Rebound While Bitcoin Edges Down: Amazon's Q3 Lifts Tech Stocks As Traders Eye Fed's Favorite Inflation Gauge
October 27, 2023
As Amazon, Inc. (NASDAQ:AMZN) hawked good tidings, the negative sentiment in the equity market appears to have reversed. The recovery could be in part due to traders looking for bargains following a...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Apple's Timepiece Trouble: Patent Dispute Puts Apple Watch Imports in Jeopardy
October 27, 2023
The U.S. International Trade Commission may ban the import of Apple Watches due to a patent infringement dispute with medical tech firm Masimo, pending a presidential review and potential appeals.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
Disney's Lost Decade and Next Act
September 13, 2023
The market's had a surprisingly strong 2023, but investors might be eying easy low-risk yields elsewhere.
Via
The Motley Fool
Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally
July 19, 2023
Via
Benzinga
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations
July 18, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77....
Via
Benzinga
Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates
July 18, 2023
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
During Tuesday's trading, 46 companies set new 52-week lows.
Via
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
Dow Jumps Over 300 Points; Morgan Stanley Posts Upbeat Earnings
July 18, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also...
Via
Benzinga
Masimo Plummets To Five-Year Low On Light Sales, 'Longer-Term' Challenges Persist
July 18, 2023
The company works primarily in health care, but its non-health care efforts are floundering.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
July 18, 2023
Via
Benzinga
CMG Stock Alert: Chipotle Announces International Expansion Plan
July 18, 2023
Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 18, 2023
Via
Benzinga
Why Is CEL-SCI (CVM) Stock Down 23% Today?
July 18, 2023
CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.